Related references
Note: Only part of the references are listed.Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases
Dang Xitong et al.
GENE (2016)
Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery
Tek N. Lamichhane et al.
MOLECULAR PHARMACEUTICS (2015)
The use of antibody modified liposomes loaded with AMO-1. to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy
Meifang Liu et al.
BIOMATERIALS (2014)
Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
Rick F. J. Kwekkeboom et al.
CLINICAL SCIENCE (2014)
An SRF/miR-1 axis regulates NCX1 and Annexin A5 protein levels in the normal and failing heart
Eva Tritsch et al.
CARDIOVASCULAR RESEARCH (2013)
Overexpression of microRNA-1 Causes Atrioventricular Block in Rodents
Yong Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling
Hongli Shan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia
Yangxin Li et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts
Antonio Curcio et al.
PLOS ONE (2013)
MicroRNA-1 Accelerates the Shortening of Atrial Effective Refractory Period by Regulating KCNE1 and KCNB2 Expression: An Atrial Tachypacing Rabbit Model
Xiaomeng Jia et al.
PLOS ONE (2013)
Therapeutic Cardiac-Targeted Delivery of miR-1 Reverses Pressure Overload-Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
Ioannis Karakikes et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway
Regalla Kumarswamy et al.
EUROPEAN HEART JOURNAL (2012)
Connexin43 Gene Transfer Reduces Ventricular Tachycardia Susceptibility After Myocardial Infarction
Ian D. Greener et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
MicroRNA-1 represses Cx43 expression in viral myocarditis
Hong-Fei Xu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
MicroRNA-1 and-133 Increase Arrhythmogenesis in Heart Failure by Dissociating Phosphatase Activity from RyR2 Complex
Andriy E. Belevych et al.
PLOS ONE (2011)
Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1
Hongli Shan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Interaction between transcription factors Iroquois proteins 4 and 5 controls cardiac potassium channel Kv4.2 gene transcription
Wenjie He et al.
CARDIOVASCULAR RESEARCH (2009)
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection
Yanjie Lu et al.
CARDIOVASCULAR RESEARCH (2009)
miR-1 Overexpression Enhances Ca2+ Release and Promotes Cardiac Arrhythmogenesis by Targeting PP2A Regulatory Subunit B56α and Causing CaMKII-Dependent Hyperphosphorylation of RyR2
Dmitry Terentyev et al.
CIRCULATION RESEARCH (2009)
Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation
Zenawit Girmatsion et al.
HEART RHYTHM (2009)
Role of slow delayed rectifier K+-current in QT prolongation in the alloxan-induced diabetic rabbit heart
Cs. Lengyel et al.
ACTA PHYSIOLOGICA (2008)
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart
Xiaobin Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
被撤回的出版物: Novel approaches for gene-specific interference manipulating actions of via microRNAS:: Examination on the pacemaker channel genes HCN2 and HCN4 (Retracted article. See vol. 227, pg. 877, 2012)
Jiening Xiao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2
Yong Zhao et al.
CELL (2007)
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2
Baofeng Yang et al.
NATURE MEDICINE (2007)
Ryanodine receptor/calcium release channel PKA phosphorylation: A critical mediator of heart failure progression
XHT Wehrens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MicroRNA1 influences cardiac differentiation in Drosophila and regulates notch signaling
C Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels
Y Kubo et al.
PHARMACOLOGICAL REVIEWS (2005)
The homeodomain transcription factor lrx5 establishes the mouse cardiac ventricular repolarization gradient
DL Costantini et al.
CELL (2005)
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
Y Zhao et al.
NATURE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Properties of the hyperpolarization-activated current (If) in isolated mouse sino-atrial cells
ME Mangoni et al.
CARDIOVASCULAR RESEARCH (2001)
Phosphorylation-dependent regulation of ryanodine receptors: A novel role for leucine/isoleucine zippers
SO Marx et al.
JOURNAL OF CELL BIOLOGY (2001)
Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43
DE Gutstein et al.
CIRCULATION RESEARCH (2001)
Share Paper
